However, for some types of cancer, such as head and neck carcinoma, it has been shown that ZEB1 overexpression increased the tumor susceptibility to ferroptosis and anti-VEGF-A treatment can be considered as an option for use in combination with ferroptosis inducers [40]. This evidence concerns the gene ZEB1 and neoplasm.